Slauson & Co.
26
3M
19
2
0.27
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 50000000
- Fund raised date
- 2021-02-24
Analytics
- Total investments
- 26
- Lead investments
- 2
- Follow on index
- 0.27
- Investments by industry
- E-Commerce (6)
- Financial Services (4)
- Marketplace (3)
- Real Estate (3)
- FinTech (3) Show 32 more
- Investments by region
- United States (23)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Avg. valuation at time of investment
- 894K
- Group Appearance index
- 0.96
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| FCTRY LAb | 14 Dec 2022 | Manufacturing, Product Design | Seed | 6M | United States, California, Los Angeles |
| Penelope Retirement | 15 Nov 2023 | Seed | 2M | United States, New York, New York |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Circular Genomics | Jan 12, 2025 | Circular RNA, Neurology, Precision Medicine, Psychiatry, Transcriptomics | - | 15000000 USD | |
| C2N Diagnostic | Sep 30, 2024 | Alzheimer’s disease-specific fluid biomarker tests, Brain health, Diagnostics | - | 15000000 USD | |
| C2N | Sep 26, 2024 | Alzheimer’s Disease Research, Brain Health, Clinical Decision-Making, Clinical Trials, Diagnostics | - | 7025000 USD | |
| CuraSen Therapeutics | Oct 16, 2023 | Alzheimer’s Disease, Neurodegenerative Disease, Parkinson’s Disease, Small Molecule Therapies | - | 5800000 USD | |
| CuraSen | Oct 16, 2023 | Neurodegenerative Disease, Receptor Activation, Small Molecule Therapies | - | 5800000 USD |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.